Dax (Performanceindex) (DAX.DAX30)

Close: 13 921.00 (-135.65), Mar 5, 2021
Weak Negative

Medium risk

Automatic technical analysis. Medium term, Mar 5, 2021

Investors have paid higher prices over time to buy Dax (Performanceindex) and the index is in a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. The index is testing the resistance at points 14100. This could give a negative reaction, but an upward breakthrough of points 14100 means a positive signal. Volume has previously been low at price tops and high at price bottoms. This weakens the rising trend and could be an early signal for a coming trend break. RSI diverges negatively against the price, which indicates a danger for a reaction down. The index is overall assessed as technically slightly negative for the medium long term.

Recommendation one to six months: Weak Negative (Score: -31)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.11%4 145.14-0.97%
5 days-84.503.79%3 703.44+0.97%
22 days-24.6310.78%3 386.46-0.09%
66 days-6.2325.31%3 558.96+4.39%

More analyses of Dax (Performanceindex)

chart Dax (Performanceindex) (DAX) Candlesticks 22 Days
Candlesticks
chart Dax (Performanceindex) (DAX) Short term
Short term: Hold
chart Dax (Performanceindex) (DAX) Medium term
Medium term: Weak Negative
chart Dax (Performanceindex) (DAX) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK